MicroRNA level in patients with stable coronary artery disease with borderline coronary artery stenosis

Aim. To assess the level of microRNA (miR) -21, -22, -126, -221 in patients with coronary artery disease (CAD) with borderline coronary artery stenosis depending on comorbidities and sex.Material and methods. We examined 37 patients with class 1-3 stable CAD aged 49-59 years with borderline (40-70%)...

Full description

Bibliographic Details
Main Authors: D. A. Yakhontov, Yu. O. Ostanina, V. V. Kononchuk, L. F. Gulyaeva, T. S. Kalinina, E. Yu. Alekseyonok, M. K. Kolyagina
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2022-11-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/5224
_version_ 1797856553285451776
author D. A. Yakhontov
Yu. O. Ostanina
V. V. Kononchuk
L. F. Gulyaeva
T. S. Kalinina
E. Yu. Alekseyonok
M. K. Kolyagina
author_facet D. A. Yakhontov
Yu. O. Ostanina
V. V. Kononchuk
L. F. Gulyaeva
T. S. Kalinina
E. Yu. Alekseyonok
M. K. Kolyagina
author_sort D. A. Yakhontov
collection DOAJ
description Aim. To assess the level of microRNA (miR) -21, -22, -126, -221 in patients with coronary artery disease (CAD) with borderline coronary artery stenosis depending on comorbidities and sex.Material and methods. We examined 37 patients with class 1-3 stable CAD aged 49-59 years with borderline (40-70%) coronary artery stenosis. The relative level of miRNA was determined using real-time polymerase chain reaction. Statistical analysis was performed using the non-parametric Mann-Whitney U-test. P<0,05 were considered statistically significant. Results. The miR-221 level was higher in the group of patients with stable CAD with borderline coronary artery stenosis with a metabolically unhealthy obesity (MUO) phenotype, but without diabetes (p=0,042). The level of miR-22 and miR-126 was higher in the group of patients with stable CAD phenotype with borderline stenosis and diabetes (p=0,007 and p=0,034, respectively). The analysis of miR levels in stable CAD patients depending on sex, without taking into account the phenotype, found that miR-21 and miR-221 values were higher in men (p=0,021 and p=0,014, respectively). The study of the sex characteristics of miR content in relation to different phenotypes revealed an increase of miR22 levels in men with MUO and diabetes (p=0,048) and an increase of miR-126 levels in women with concomitant diabetes in the comparison both with patients without MUO and diabetes (p=0,018), as well as with MUO and without diabetes (p=0,007). Conclusion. The study of the miRNA level in patients with CAD with borderline coronary artery stenosis is of great interest and reflects a promising direction in diagnosis based on comorbid pathology. Keywords: miRNA, obesity phenotypes, coronary artery disease, borderline coronary artery stenosis. Relationships and Activities: none. 1Novosibirsk State Medical University, Novosibirsk; 2Federal Research Center of Fundamental and Translational Medicine, Novosibirsk; 3E.N. Meshalkin National Medical Research Center, Novosibirsk, Russia.><0,05 were considered statistically significant.Results. The miR-221 level was higher in the group of patients with stable CAD with borderline coronary artery stenosis with a metabolically unhealthy obesity (MUO) phenotype, but without diabetes (p=0,042). The level of miR-22 and miR-126 was higher in the group of patients with stable CAD phenotype with borderline stenosis and diabetes (p=0,007 and p=0,034, respectively). The analysis of miR levels in stable CAD patients depending on sex, without taking into account the phenotype, found that miR-21 and miR-221 values were higher in men (p=0,021 and p=0,014, respectively). The study of the sex characteristics of miR content in relation to different phenotypes revealed an increase of miR22 levels in men with MUO and diabetes (p=0,048) and an increase of miR-126 levels in women with concomitant diabetes in the comparison both with patients without MUO and diabetes (p=0,018), as well as with MUO and without diabetes (p=0,007).Conclusion. The study of the miRNA level in patients with CAD with borderline coronary artery stenosis is of great interest and reflects a promising direction in diagnosis based on comorbid pathology.
first_indexed 2024-04-09T20:43:22Z
format Article
id doaj.art-6b9267ee7142489881c0a7cf620c3f80
institution Directory Open Access Journal
issn 1560-4071
2618-7620
language Russian
last_indexed 2024-04-09T20:43:22Z
publishDate 2022-11-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj.art-6b9267ee7142489881c0a7cf620c3f802023-03-29T21:23:42Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202022-11-01271010.15829/1560-4071-2022-52243686MicroRNA level in patients with stable coronary artery disease with borderline coronary artery stenosisD. A. Yakhontov0Yu. O. Ostanina1V. V. Kononchuk2L. F. Gulyaeva3T. S. Kalinina4E. Yu. Alekseyonok5M. K. Kolyagina6Novosibirsk State Medical UniversityNovosibirsk State Medical UniversityFederal Research Center of Fundamental and Translational Medicine; E.N. Meshalkin National Medical Research CenterFederal Research Center of Fundamental and Translational MedicineFederal Research Center of Fundamental and Translational MedicineFederal Research Center of Fundamental and Translational MedicineFederal Research Center of Fundamental and Translational MedicineAim. To assess the level of microRNA (miR) -21, -22, -126, -221 in patients with coronary artery disease (CAD) with borderline coronary artery stenosis depending on comorbidities and sex.Material and methods. We examined 37 patients with class 1-3 stable CAD aged 49-59 years with borderline (40-70%) coronary artery stenosis. The relative level of miRNA was determined using real-time polymerase chain reaction. Statistical analysis was performed using the non-parametric Mann-Whitney U-test. P<0,05 were considered statistically significant. Results. The miR-221 level was higher in the group of patients with stable CAD with borderline coronary artery stenosis with a metabolically unhealthy obesity (MUO) phenotype, but without diabetes (p=0,042). The level of miR-22 and miR-126 was higher in the group of patients with stable CAD phenotype with borderline stenosis and diabetes (p=0,007 and p=0,034, respectively). The analysis of miR levels in stable CAD patients depending on sex, without taking into account the phenotype, found that miR-21 and miR-221 values were higher in men (p=0,021 and p=0,014, respectively). The study of the sex characteristics of miR content in relation to different phenotypes revealed an increase of miR22 levels in men with MUO and diabetes (p=0,048) and an increase of miR-126 levels in women with concomitant diabetes in the comparison both with patients without MUO and diabetes (p=0,018), as well as with MUO and without diabetes (p=0,007). Conclusion. The study of the miRNA level in patients with CAD with borderline coronary artery stenosis is of great interest and reflects a promising direction in diagnosis based on comorbid pathology. Keywords: miRNA, obesity phenotypes, coronary artery disease, borderline coronary artery stenosis. Relationships and Activities: none. 1Novosibirsk State Medical University, Novosibirsk; 2Federal Research Center of Fundamental and Translational Medicine, Novosibirsk; 3E.N. Meshalkin National Medical Research Center, Novosibirsk, Russia.><0,05 were considered statistically significant.Results. The miR-221 level was higher in the group of patients with stable CAD with borderline coronary artery stenosis with a metabolically unhealthy obesity (MUO) phenotype, but without diabetes (p=0,042). The level of miR-22 and miR-126 was higher in the group of patients with stable CAD phenotype with borderline stenosis and diabetes (p=0,007 and p=0,034, respectively). The analysis of miR levels in stable CAD patients depending on sex, without taking into account the phenotype, found that miR-21 and miR-221 values were higher in men (p=0,021 and p=0,014, respectively). The study of the sex characteristics of miR content in relation to different phenotypes revealed an increase of miR22 levels in men with MUO and diabetes (p=0,048) and an increase of miR-126 levels in women with concomitant diabetes in the comparison both with patients without MUO and diabetes (p=0,018), as well as with MUO and without diabetes (p=0,007).Conclusion. The study of the miRNA level in patients with CAD with borderline coronary artery stenosis is of great interest and reflects a promising direction in diagnosis based on comorbid pathology.https://russjcardiol.elpub.ru/jour/article/view/5224mirnaobesity phenotypescoronary artery diseaseborderline coronary artery stenosis
spellingShingle D. A. Yakhontov
Yu. O. Ostanina
V. V. Kononchuk
L. F. Gulyaeva
T. S. Kalinina
E. Yu. Alekseyonok
M. K. Kolyagina
MicroRNA level in patients with stable coronary artery disease with borderline coronary artery stenosis
Российский кардиологический журнал
mirna
obesity phenotypes
coronary artery disease
borderline coronary artery stenosis
title MicroRNA level in patients with stable coronary artery disease with borderline coronary artery stenosis
title_full MicroRNA level in patients with stable coronary artery disease with borderline coronary artery stenosis
title_fullStr MicroRNA level in patients with stable coronary artery disease with borderline coronary artery stenosis
title_full_unstemmed MicroRNA level in patients with stable coronary artery disease with borderline coronary artery stenosis
title_short MicroRNA level in patients with stable coronary artery disease with borderline coronary artery stenosis
title_sort microrna level in patients with stable coronary artery disease with borderline coronary artery stenosis
topic mirna
obesity phenotypes
coronary artery disease
borderline coronary artery stenosis
url https://russjcardiol.elpub.ru/jour/article/view/5224
work_keys_str_mv AT dayakhontov micrornalevelinpatientswithstablecoronaryarterydiseasewithborderlinecoronaryarterystenosis
AT yuoostanina micrornalevelinpatientswithstablecoronaryarterydiseasewithborderlinecoronaryarterystenosis
AT vvkononchuk micrornalevelinpatientswithstablecoronaryarterydiseasewithborderlinecoronaryarterystenosis
AT lfgulyaeva micrornalevelinpatientswithstablecoronaryarterydiseasewithborderlinecoronaryarterystenosis
AT tskalinina micrornalevelinpatientswithstablecoronaryarterydiseasewithborderlinecoronaryarterystenosis
AT eyualekseyonok micrornalevelinpatientswithstablecoronaryarterydiseasewithborderlinecoronaryarterystenosis
AT mkkolyagina micrornalevelinpatientswithstablecoronaryarterydiseasewithborderlinecoronaryarterystenosis